PharVision Advisers’s Canadian Solar CSIQ Stock Holding History

PharVision Advisers’s Portfolio CSIQ Stock Details CSIQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,402	Closed	-$159K	–	684
2025 Q2	$159K	Buy	+14,402	New	+$139K	0.23%	224

Other funds holding CSIQ

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

PharVision Advisers's CSIQ Position: Q3 2025 in Review

PharVision Advisers sold out of Canadian Solar (CSIQ) in Q3 2025, closing a stake of 14,402 shares — an estimated $159K sold.

PharVision Advisers first reported a position in CSIQ in Q2 2025 and held it in 1 quarter. The position peaked at $159K in Q2 2025. 116 funds tracked by Wall St. Rank hold CSIQ as of Q3 2025.

PharVision Advisers reported no remaining Canadian Solar position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 14,402 Canadian Solar shares in Q3 2025, an estimated $159K.
PharVision Advisers first reported a position in Canadian Solar in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Canadian Solar position peaked at $159K in Q2 2025.
116 funds tracked by Wall St. Rank held Canadian Solar as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.